ANXA5 can regulate phosphatidylserine (PS)-mediated immunosuppression by binding to PS, increasing the immunogenicity of apoptotic cells, thereby enhancing the immunosuppression of the tumor microenvironment (37). This evidence concerns the gene ANXA5 and neoplasm.